Eating and Weight Disorders Program, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA.
Addict Behav. 2011 Oct;36(10):949-58. doi: 10.1016/j.addbeh.2011.05.002. Epub 2011 May 11.
Appearance-and-performance enhancing drug (APED) use is a form of drug use that includes use of a wide range of substances such as anabolic-androgenic steroids (AASs) and associated behaviors including intense exercise and dietary control. To date, there are no reliable or valid measures of the core features of APED use. The present study describes the development and psychometric evaluation of the Appearance and Performance Enhancing Drug Use Schedule (APEDUS) which is a semi-structured interview designed to assess the spectrum of drug use and related features of APED use. Eighty-five current APED using men and women (having used an illicit APED in the past year and planning to use an illicit APED in the future) completed the APEDUS and measures of convergent and divergent validity. Inter-rater agreement, scale reliability, one-week test-retest reliability, convergent and divergent validity, and construct validity were evaluated for each of the APEDUS scales. The APEDUS is a modular interview with 10 sections designed to assess the core drug and non-drug phenomena associated with APED use. All scales and individual items demonstrated high inter-rater agreement and reliability. Individual scales significantly correlated with convergent measures (DSM-IV diagnoses, aggression, impulsivity, eating disorder pathology) and were uncorrelated with a measure of social desirability. APEDUS subscale scores were also accurate measures of AAS dependence. The APEDUS is a reliable and valid measure of APED phenomena and an accurate measure of the core pathology associated with APED use. Issues with assessing APED use are considered and future research is considered.
外观和表现增强药物(APED)的使用是一种药物使用形式,包括使用广泛的物质,如合成代谢雄激素类固醇(AAS)和相关行为,包括剧烈运动和饮食控制。迄今为止,还没有可靠或有效的方法来衡量 APED 使用的核心特征。本研究描述了外观和表现增强药物使用时间表(APEDUS)的开发和心理测量评估,这是一种半结构化访谈,旨在评估药物使用的范围和 APED 使用的相关特征。85 名目前正在使用 APED 的男性和女性(过去一年中使用过非法 APED,并计划在未来使用非法 APED)完成了 APEDUS 以及聚合和发散有效性的测量。评估了 APEDUS 每个量表的评分者间一致性、量表可靠性、一周重测信度、聚合和发散有效性以及结构有效性。APEDUS 是一个具有 10 个部分的模块化访谈,旨在评估与 APED 使用相关的核心药物和非药物现象。所有量表和个别项目都表现出较高的评分者间一致性和可靠性。个别量表与聚合性测量(DSM-IV 诊断、攻击性、冲动性、饮食障碍病理)显著相关,与社会期望测量无关。APEDUS 子量表得分也是 AAS 依赖的准确衡量标准。APEDUS 是一种可靠和有效的 APED 现象衡量标准,也是 APED 使用相关核心病理的准确衡量标准。考虑到评估 APED 使用的问题,并考虑了未来的研究。